Mirum Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
CEOChristopher Peetz
CEOChristopher Peetz
Employees322
Employees322
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2018
Founded2018
Employees322
Employees322
MIRM Key Statistics
Market cap3.90B
Market cap3.90B
Price-Earnings ratio-63.92
Price-Earnings ratio-63.92
Dividend yield—
Dividend yield—
Average volume907.52K
Average volume907.52K
High today$77.69
High today$77.69
Low today$74.89
Low today$74.89
Open price$76.67
Open price$76.67
Volume602.27K
Volume602.27K
52 Week high$78.10
52 Week high$78.10
52 Week low$36.86
52 Week low$36.86
MIRM News
TipRanks 1d
Mirum Pharmaceuticals completes enrollment in VISTAS study of volixibatMirum Pharmaceuticals (MIRM) announced the completion of enrollment in the Phase 2b VISTAS study of volixibat, an investigational oral IBAT inhibitor, for the t...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.